Raymond James & Associates lessened its stake in Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM – Free Report) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,371,535 shares of the company’s stock after selling 14,640 shares during the period. Raymond James & Associates’ holdings in Goldman Sachs ActiveBeta Emerging Markets Equity ETF were worth $48,155,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the stock. &PARTNERS purchased a new position in shares of Goldman Sachs ActiveBeta Emerging Markets Equity ETF in the second quarter valued at about $318,000. LPL Financial LLC increased its holdings in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 3.6% during the 2nd quarter. LPL Financial LLC now owns 1,499,824 shares of the company’s stock valued at $48,999,000 after purchasing an additional 51,990 shares during the period. Truist Financial Corp increased its holdings in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 10.8% during the 2nd quarter. Truist Financial Corp now owns 20,370 shares of the company’s stock valued at $665,000 after purchasing an additional 1,980 shares during the period. Atria Wealth Solutions Inc. raised its position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 6.2% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 25,720 shares of the company’s stock valued at $840,000 after purchasing an additional 1,500 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. lifted its holdings in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 2.8% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 148,959 shares of the company’s stock worth $4,866,000 after buying an additional 4,061 shares during the period.
Goldman Sachs ActiveBeta Emerging Markets Equity ETF Stock Performance
GEM opened at $34.68 on Wednesday. The stock has a market capitalization of $1.03 billion, a PE ratio of 10.62 and a beta of 0.79. The stock’s 50 day moving average price is $33.89 and its 200-day moving average price is $32.89. Goldman Sachs ActiveBeta Emerging Markets Equity ETF has a 52-week low of $27.54 and a 52-week high of $36.16.
Goldman Sachs ActiveBeta Emerging Markets Equity ETF Company Profile
The Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of emerging market stocks comprising 4 sub-indexes: value, momentum, quality, and low volatility. The index uses multiple factors to pick stocks, and each sub-index receives equal weight.
Featured Articles
- Five stocks we like better than Goldman Sachs ActiveBeta Emerging Markets Equity ETF
- The 3 Best Fintech Stocks to Buy Now
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- 3 Tickers Leading a Meme Stock Revival
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- 3 REITs to Buy and Hold for the Long Term
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Want to see what other hedge funds are holding GEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM – Free Report).
Receive News & Ratings for Goldman Sachs ActiveBeta Emerging Markets Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Goldman Sachs ActiveBeta Emerging Markets Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.